25 April 2024
Investor Briefing with Michael Macilquham and Charlie Bell
In this session Nicolab’s CEO Michael Macilquham and CFO Charlie Bell discussed the key highlights:
- How Nicolab’s AI-driven solution is dramatically accelerating stroke diagnosis and treatment.
- Their traction around commercial contracts across the globe and their partnership with giant Philips.
- Nicolab’s scale up plans in the US and Europe as they target an IPO or trade sale.
Recorded on 22nd April 2024 at 12pm (AEST).
COMPANY UPDATES
Company Updates
22 April 2024
Nicolab Investor Briefing
Company Updates
18 April 2024
Far East Gold Investor Briefing
Open investments
View allZetaris
Request Offer DocsInvestment Type:
Convertible NoteOur Role:
Aussie big data company enabling large corporations to leverage AI.Nicolab
Request Offer DocsInvestment Type:
EquityOur Role:
Global medtech company using AI to accelerate diagnosis in medical emergencies.Technology AI
Request Offer DocsInvestment Type:
EquityOur Role:
A company using AI to digitally measure and track user engagement in a physical space the same way online user behaviour can be tracked.upcoming events
View allUpcoming Events
Monday, 6th May 7pm (AEST)